OB/GYN Clinical Alert – December 1, 2003
December 1, 2003
View Issues
-
Trends in Surgery and Chemotherapy for Women Diagnosed with Ovarian Cancer in the United States
Despite guidelines presented by several organizations, significant numbers of women with ovarian cancer are not being provided with appropriate care. -
Have You Heard About Equol?
People are either equol producers or nonequol producers, and the clinical benefits of soy isoflavones may be limited to equol producers. -
Reducing Blood Loss and Time in Vaginal Hysterectomy
An electrosurgical bipolar vessel sealer reduces the operating time and blood loss in a series of vaginal hysterectomies. -
Fetal Myelomeningocele Repair: Short-Term Clinical Outcomes
Early experience with fetal MMC repair suggests a decreased need for ventriculoperitoneal shunting, arrest, or slowing of progressive ventriculomegaly, and consistent resolution of hindbrain herniation. -
A (Not Really So) Rare Cause of a Common Presentation
Menstrual irregularities are arguably the mainstay of gynecologic office practice. The differential diagnosis for this common presentation is quite extensive, but a common cause is reduced central hypothalamic GnRH drive due to lifestyle issues. -
Pharmacology Watch: Eplerenone Cleared for CHF Patients with Sustained MI
The FDA has approved Pfizer's eplerenone (Inspra) for the treatment of congestive heart failure (CHF) in patients who have sustained a myocardial infarction.